Dabur India Limited DABUR NIFTY_MIDNSE
Dabur India Limited operates as a fast moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company provides health supplements under the Dabur Chyawanprash, Dabur Honey, and Dabur Glucose brand name; digestive products under the Hajmola and Pudin Hara; cough and cold products under the Honitus brands name; rejuvenators under the Shilajit brand name; health juices; nutraceuticals under the Siens brand name; and baby care products under the Dabur Lal Tail, Janma Ghunti, Gripe Water, and Dabur Baby brand names, as well as Ayurvedic Ethicals. It also offers hair care products under the Dabur Amla Hair Oil, Vatika, and Cool King brands; oral care products under the Dabur Red Toothpaste, Dabur Meswak, and Dabur Herb'l Toothpaste brand names; skin care products, including rose water, moisturising creams and lotions, soaps, body wash, toners, facial bleaches, and depilatory creams under the Dabur Gulabari and Fem & OxyLife brand names; and home care products, such as air fresheners under Odonil name, mosquito repellents under the Odomos brand, and surface cleaners under the Sanifresh brand name. In addition, the company provides beverages under the Réal and Réal Activ brand names; foods under the Dabur and Hommade brands; and spices under the Badshah brand, as well as edible oils and ghee which includes Dabur Cold Pressed Mustard Oil, Dabur Cold Pressed Sesame Oil, Dabur Cold Pressed Groundnut Oil, Dabur Virgin Coconut Oil and Dabur 100% Cow Ghee. It also operates specialized beauty retail stores that offer a range of cosmetics, fragrances, skin care, and personal care products, as well as beauty and fashion accessories under the NewU brand name. Dabur India Limited was founded in 1884 and is based in Ghaziabad, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Healthy ROCE of 21.0%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DABUR Dabur India Limited NIFTY_MIDNSE | 443.40 | 41.67 | ₹78,645.42 Cr | 1.86% | 20.96% | 16.24% | 4.91% | 3.54% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,153.50 | 47.62 | ₹5.06 L Cr | 2.04% | 22.15% | 21.60% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 286.90 | 17.39 | ₹3.59 L Cr | 5.58% | 36.47% | 29.34% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,421.50 | 78.10 | ₹2.74 L Cr | 0.84% | 59.30% | 76.34% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 4,054.50 | 88.49 | ₹2.64 L Cr | - | 16.41% | 12.94% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 528.00 | 56.17 | ₹1.79 L Cr | 0.38% | 19.44% | - | 17.26% | 26.57% |
| 7 | TATACONSUM Tata Consumer Products Limited NIFTY50NSE | 1,178.40 | 75.78 | ₹1.17 L Cr | 0.85% | 8.29% | 6.94% | 13.87% | 8.61% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 821.70 | 60.60 | ₹1.06 L Cr | 0.49% | 39.00% | 41.39% | 12.00% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,029.30 | 56.49 | ₹1.05 L Cr | 1.94% | 21.44% | 15.10% | 4.59% | 3.02% |
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 3,355.25 Cr | 2,830.14 Cr | 3,404.58 Cr | 3,558.65 Cr | 3,038.02 Cr |
| Cost of Revenue | 1,742.84 Cr | 1,509.06 Cr | 1,803.26 Cr | 1,836.90 Cr | 1,570.09 Cr |
| Gross Profit | 1,612.41 Cr | 1,321.08 Cr | 1,601.32 Cr | 1,721.75 Cr | 1,467.93 Cr |
| Operating Expenses | 1,039.16 Cr | 1,011.08 Cr | 1,047.64 Cr | 1,104.81 Cr | 1,128.31 Cr |
| Operating Income | 573.25 Cr | 310.00 Cr | 553.68 Cr | 616.94 Cr | 339.62 Cr |
| EBITDA | 810.42 Cr | 568.03 Cr | 811.39 Cr | 859.42 Cr | 635.85 Cr |
| Interest Expense | 44.20 Cr | 39.25 Cr | 34.63 Cr | 31.12 Cr | 39.97 Cr |
| Pretax Income | 657.58 Cr | 411.91 Cr | 662.62 Cr | 711.11 Cr | 473.68 Cr |
| Tax Provision | 141.76 Cr | 99.18 Cr | 154.33 Cr | 157.50 Cr | 111.68 Cr |
| Net Income | 522.38 Cr | 320.13 Cr | 513.91 Cr | 559.97 Cr | 368.60 Cr |
| Diluted EPS | 2.94 | 1.80 | 2.89 | 3.15 | 2.07 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 11,426.51 Cr | 12,261.65 Cr | 12,563.09 Cr | 13,192.57 Cr |
| Cost of Revenue | - | 6,316.09 Cr | 6,496.41 Cr | 6,534.86 Cr | 6,823.77 Cr |
| Gross Profit | - | 5,110.42 Cr | 5,765.24 Cr | 6,028.23 Cr | 6,368.80 Cr |
| Operating Expenses | - | 3,241.91 Cr | 3,746.48 Cr | 4,157.49 Cr | 4,385.89 Cr |
| Operating Income | - | 1,868.51 Cr | 2,018.76 Cr | 1,870.74 Cr | 1,982.91 Cr |
| EBITDA | - | 2,598.78 Cr | 2,868.13 Cr | 2,866.99 Cr | 3,034.76 Cr |
| Interest Expense | - | 69.14 Cr | 110.18 Cr | 163.50 Cr | 145.40 Cr |
| Pretax Income | - | 2,218.68 Cr | 2,358.74 Cr | 2,257.89 Cr | 2,420.43 Cr |
| Tax Provision | - | 517.35 Cr | 547.43 Cr | 517.47 Cr | 551.74 Cr |
| Net Income | - | 1,707.15 Cr | 1,842.68 Cr | 1,767.63 Cr | 1,895.03 Cr |
| Diluted EPS | - | 9.61 | 10.38 | 9.95 | 10.66 |
Compounded Sales Growth
| 5 Years: | 4.91% |
| 1 Year: | 7.30% |
Compounded Profit Growth
| 5 Years: | 3.54% |
| 1 Year: | 15.20% |
Stock Price Performance
| 1 Year: | -6.61% |
| 6 Months: | -13.80% |
| 3 Months: | -14.41% |
| 1 Month: | +0.43% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 13,654.37 Cr | 15,122.68 Cr | 16,232.28 Cr | 17,479.91 Cr |
| Current Assets | - | 4,248.96 Cr | 5,679.62 Cr | 6,532.46 Cr | 8,885.96 Cr |
| Cash & Equivalents | - | 146.81 Cr | 247.59 Cr | 184.17 Cr | 199.37 Cr |
| Inventory | - | 2,024.20 Cr | 1,946.97 Cr | 2,300.11 Cr | 2,321.63 Cr |
| Receivables | - | 848.75 Cr | 898.72 Cr | 888.50 Cr | 715.41 Cr |
| Total Liabilities | - | 4,212.94 Cr | 4,819.60 Cr | 5,022.02 Cr | 5,677.16 Cr |
| Current Liabilities | - | 3,609.43 Cr | 3,930.43 Cr | 4,318.44 Cr | 5,239.08 Cr |
| Long Term Debt | - | 298.84 Cr | 535.97 Cr | 303.74 Cr | 15.96 Cr |
| Total Debt | - | 1,173.79 Cr | 1,365.09 Cr | 950.08 Cr | 1,287.32 Cr |
| Total Equity | - | 8,973.26 Cr | 9,866.30 Cr | 10,800.69 Cr | 11,419.52 Cr |
| Shares Outstanding | - | 177.18 Cr | 177.20 Cr | 177.23 Cr | 177.37 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 1,488.43 Cr | 2,013.47 Cr | 1,986.75 Cr | 2,578.62 Cr |
| Investing Cash Flow | - | -586.54 Cr | -971.74 Cr | -449.11 Cr | -1,285.22 Cr |
| Financing Cash Flow | - | -1,035.24 Cr | -1,161.18 Cr | -1,405.34 Cr | -1,235.73 Cr |
| Capital Expenditure | - | -509.09 Cr | -563.86 Cr | -569.54 Cr | -420.14 Cr |
| Free Cash Flow | - | 979.34 Cr | 1,449.61 Cr | 1,417.21 Cr | 2,158.48 Cr |
| Net Change in Cash | - | -133.35 Cr | -119.45 Cr | 132.30 Cr | 57.67 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 44.7% | 47.0% | 48.0% | 48.3% |
| Operating Margin % | - | 16.4% | 16.5% | 14.9% | 15.0% |
| Net Margin % | - | 14.9% | 15.0% | 14.1% | 14.4% |
| ROE % | - | 19.0% | 18.7% | 16.4% | 16.6% |
| ROCE % | - | 18.6% | 18.0% | 15.7% | 16.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DABUR